Author:
Zeng Long-Jia,Xiang Chun-Lin,Gong Yi-Zhen,Kuang Yan,Lu Fang-Fang,Yi Su-Yi,Zhang Yue,Liao Meng
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Kehoe, S. et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet. 386, 249–257 (2015).
2. Vergote, I. et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N. Engl. J. Med. 363, 943–953 (2010).
3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: original cancer including fallopian tube cancer and primary peritoneal cancer. v. 2. Avaible at
www.nccn.org
(2015).
4. Rose, P. G. et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N. Engl. J. Med. 351, 2489–2497 (2004).
5. van der Burg, M. E. et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N. Engl. J. Med. 332, 629–634 (1995).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献